Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy

18Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A high prevalence of monoclonal gammopathy (MG) has been observed in HIV-infected patients. We explored the conditions associated with long-term persistence of serum monoclonal protein (M protein) in HIV-infected patients on antiretroviral therapy (ART). Of 21patients with MG,Mprotein disappearedin12patients (58%) over5yearsofART.Higher level of serum γ-globulin and higher percentages of circulating plasmablasts and plasma cells were observed in patients with persistent MG compared with patients with transient MG. MG persistence was associated with the cumulative time of detectable plasma HIV RNA after ART initiation, detection of Epstein-Barr virus (EBV) DNA in plasma, and a high level of EBV DNA in B cells. Poor control of HIV replication and detectable EBV replication in plasma were both associated with long-term MG persistence in patients on ART. In the case of viral control, MG associated with HIV infection is usually transient. © 2013 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Ouedraogo, D. E., Makinson, A., Vendrell, J. P., Casanova, M. L., Nagot, N., Cezar, R., … Tuaillon, E. (2013). Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy. Blood, 122(17), 3030–3033. https://doi.org/10.1182/blood-2012-12-470393

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free